Medical supply firm Medline set to debut after biggest IPO of 2025 ⊕
Medline priced at $29 per share on Tuesday, raising $6.26 billion to cap off a strong year for new listings and bolster optimism about 2026.
You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.